My understanding is that the formula shortage is slowly abating, given the number of firms applying for approval FDA is reassessing the level of actual demand. These things are never as simple as you want them to be.
Deferral is not rejection! This looks like a pause whilst they clean house, page-15
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.91 |
Change
0.010(0.17%) |
Mkt cap ! $4.304B | |||
| Open | High | Low | Value | Volume |
| $6.03 | $6.07 | $5.90 | $11.63M | 1.961M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16042 | $5.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.91 | 2504 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| A2M (ASX) Chart |